Hemodialysis bone disease: Correlation between clinical, histological and other findings. This paper explores in patients with dialysis osteodystrophy the relationship between clinical features and histological, radiological, and biochemical findings. Eightyfive patients treated by hemodialysis for more than 6 months were studied. The following conclusions were drawn: 1) Bone pain in patients on regular hemodialysis is usually a symptom of developing osteomalacia but not of hyperparathyroidism or osteoporosis. 2) Many patients with histological osteomalacia and radiological features of osteomalacia, such as fractures or Looser zones, have no symptoms. 3) In dialysis patients, biochemical and radiological abnormalities are not a reliable means of predicting the presence of osteomalacia, but a raised serum alkaline phosphatase is a good indicator of the presence of osteitis fibrosa. For early detection of osteomalacia, bone biopsy is necessary. 4) A number of our dialysis patients develop an unusual form of osteomalacia charactenzed by absent or minimal histological osteitis fibrosa, a normal serum alkaline phosphatase, and a high incidence of myopathy and fractures. 
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Ostéopathie de l'hémodialyse: Correlation entre les constata- Although most patients on regular hemodialysis show histologic abnormalities on iliac bone biopsies [1-31, relatively few have symptoms of bone disease [4] [5] . The pattern of bone disease varies considerably between dialysis centers [6-91, with a high incidence of symptomatic disease in Newcastle upon Tyne. Relatively few studies have explored the correlations between clinical, biochemic, histologic, and radiologic findings 15, [10] [11] [12] [13] [14] [15] [16] , and they have produced conflicting conclusions. We have recently described the correlation between radiology and histology in 70 of our regular hemodialysis patients [171, and we now present an analysis of the relationship between clinical features and the biochemic, radiologic, and histologic findings in an overlapping group of 85 patients.
Methods
The 85 patients studied had been on regular hemodialysis for 6 to 96 months. Although most bone biopsies were performed as part of a survey of the incidence of histological abnormalities in the bone of patients on regular hemodialysis, some were performed to investigate troublesome symptoms, and there is some bias in the selection, with a particularly high number of patients with myopathy and bone pain. The age range was from 18 to 61 yr, and there were 51 males and 34 females. The patients were on a 60-g protein diet with supplements of vitamins B and C. They received dialysis therapy of six to eight hour's duration three times per week, mainly with Kiil type dialyzers and with a dialy sate calcium of 1.6 mmoles/liter. Seven patients had been taking either dihydrotachysterol or vitamin D2 for at least six months before they were studied, and 35 had been on aluminium hydroxide, 6 with calcium carbonate sup- plements, for a similar period. We excluded from the study any patients in whom there had been a change in such therapy during the six months before the study, in case the time courses of any clinical, radiologic, biochemic, or histologic changes induced by such changes in therapy were not parallel.
Clinical information was obtained using a standard questionnaire, followed by discussion with the doctor and clinical examination. Complaints of muscle weakness were classified as subjective weakness. if on clinical examination the patient was unable to rise from the squatting position unaided three times in succession, this was classified as objective weakness. Bone pain was regarded as being due to osteodystrophy if no other cause was apparent.
Biochemical parameters. The mean results of predialysis estimations of serum calcium, phosphate, and alkaline phosphatase for the preceding three months before bone biopsy were used for analysis.
Quantitative histologic analysis of iliac crest bone biopsies was performed using the features listed in 
Results
Bone pain attributable to dialysis osteodystrophy was present in 37 (44%) patients. Subjective weakness was present in 39 (46%) patients, but only 24 (28%) had objective weakness. In seven patients, the combination of pain and weakness led to severe limitation of physical acitivity with inability to walk unaided. Histologic osteomalacia was found in 60 (71%) patients, and osteitis fibrosa in 68 (80%). Radiological fractures or Looser zones were present in 31(37%) patients, and subperiosteal erosions in 29
When the clinical symptoms were compared with the histologic findings (Table 3) , it was found that bone pain is associated with the histologic features of osteomalacia but not with that of osteitis fibrosa.
There is no association between bone pain and histologic osteoporosis or osteosclerosis. Radiologic features of osteitis fibrosa, such as subperiosteal erosions and skull mottling, showed no association with bone pain (Table 4) . As expected, there is a significant association between bone pain and radiologic fractures or Looser zones, but it is interesting that 30% of patients with fractures were asymptomatic and that 45% of those with bone pain had no fractures, showing that fractures are not the sole source of bone pain. Patients with severe degrees ofjuxtaarticular or medullary rarefaction in the metacarpals suffered pain more frequently than the others. a Percentage figures represent the proportion of people with each histologic or radiologic feature who have the specified symptom, i.e., 57% of people with a low total bone have bone pain, 21% of patients with osteitis fibrosa grade > 2.5 have objective muscle weakness.
b NS denotes P > 0.1. Numbers in parentheses indicate the total number of patients with that finding. See Table 1 for normal range. In these columns, x2 and hence P was obtained by comparing the high or low value with all other patients. Objective muscle weakness tends to be more common in patients with histologic osteomalacia and is significantly associated with the presence of fractures and Looser zones (Tables 3 and 4) . Myopathy also tends to be associated with low total bone and low mineralized bone histologically and with severe degrees of juxtaarticular rarefaction radiologically. There is no association between myopathy and the histologic or radiologic features of osteitis fibrosa.
An elevated serum alkaline phosphatase (above 90 lU/liter) was found in 47 (55%) patients; it is associated with histologic osteitis fibrosa but not with osteomalacia (Fig. 1 ). An elevated serum alkaline phosphatase is associated with the presence of radiologic erosions, skull mottling, and sclerosis of the spine, but not with fractures, Looser zones, or rarefaction scores ( Table 5 ). The serum alkaline phosphatase correlates well with total osteoid (Fig. 2) and also with total bone (r = 0.97, P < 0.0001).
Predialysis serum calcium was below 2.05 mmoles/liter in 20% of patients and above 2.55 mmoles/liter in 10%. There is no association between serum calcium levels and any clinical, histologic, or radiologic finding. Predialysis serum phosphate was elevated (above 1.6 mmoles/liter) in 74% of patients, below 1.2 mmoles/liter in four patients, and subnormal (below 0.8 mmoles/liter) in no patients. Serum phosphate levels do not relate to any clinical, radiologic, or histologic finding.
Discussion
Dialysis osteodystrophy has many components, including osteomalacia, osteitis fibrosa, osteoporosis, and osteosclerosis. There are probably many factors influencing the appearance of each component. There is not simply a progression of the osteodystrophy of chronic renal failure [211. Our patients with chronic renal failure who have not yet been dialyzed have predominant osteitis fibrosa, with Osteomalacia sometimes occurring in addition but rarely, if ever, alone: in our dialysis population, osteomalacia increases in frequency and often develops independently of osteitis fibrosa. The incidence of symptomatic dialysis osteodystrophy varies enormously between dialysis centers [6, 7, 221 . We and others [41 have felt that this may reflect the differing histologic changes seen in each center, centers with a high incidence of hyperparathyroidism having a low incidence of symptoms [9, 12] and centers with a high incidence of symptoms having a high incidence of osteomalacia [19, 23] . The data presented here supports this idea for, as in nonrenal bone disease, bone pain is almost exclusively related to osteomalacia and not osteitis fibrosa or osteoporosis. Bone pain is not entirely confined to patients with osteomalacia: five of 25 patients without it have pain. Of these five, one developed osteomalacia and fractures within six months, one had mild osteitis fibrosa and died shortly after being studied, one had severe hyperparathyroidism with fractures, both fractures and pain disappearing on therapy with dihydrotachysterol, and the remaining two patients had severe osteitis fibrosa (grades 3 and 3.5), and also died shortly after study. Thus, in three of these patients, severe osteitis fibrosa seems to have been the cause of bone pain. In centers with a high incidence of florid osteitis fibrosa, this may contribute to disability, especially with regard to fractures, tendon rupture, and ectopic calcification [9, 24] .
Although the onset of bone pain in a dialysis patient strongly suggests developing osteomalacia, this cannot be relied upon to detect this lesion, as 47% of patients with osteomalacia had no symptoms. Similarly, radiologic changes, such as nonhealing rib fractures and Looser zones in the pubic rami, were found in many asymptomatic patients. Bone biopsy is the only certain way of detecting the early development of this potentially disabling condition.
The osteomalacia seen in our dialysis patients has several unusual features not seen in most other forms of osteomalacia or in predialysis renal osteodystrophy. Serum alkaline phosphatase levels are often normal (Fig. 1) , and bone biopsy specimens often lack histologic evidence of osteitis fibrosa and show inactive bones with very few active osteoblasts, a!-though osteitis fibrosa was often present in previous biopsies from these patients. A similar picture may be seen with hypophosphatemia [25] , but serum phosphate levels were not low in our patients and were not different in groups of patients with different histological patterns of dialysis osteodystrophy.
It is the patients with normal alkaline phosphatase" osteomalacia who had the most disabling pain and fractures, and it is in this group of patients that myopathy is especially common, occurring in 13 of 29 such patients (45%) compared with 20% of the remainder, (x2 = 5.98, P < 0.05). Our patients with this form of osteomalacia have failed to respond to therapy with l-a-hydroxylated vitamin D derivatives [211. In our experience, like that of Ritz [26] , myopathy in these patients, unlike predialysis patients, also fails to respond to therapy with vitamin D derivatives.
The role of osteoporosis in producing symptoms is difficult to define. The high standard error in histologic examination of mineralized bones due to the variation in bone biopsy site [1] renders assessment of individual biopsies difficult, and histologic and radiologic changes do not always parallel one another. We have reported a high incidence of osteoporosis in our dialysis population on the basis of a high incidence ofjuxtaarticular and medullary rarefaction on radiograph [191. Medullary rarefaction, however, has been shown to correlate closely with osteomalacia [17] , which may explain the association found here between this and bone pain. Juxtaarticular rarefaction in a recent survey did not correlate with any histologic picture [17] . From our study, no significant association between histologic osteoporosis and 0.1 bone pain has been found. We must await the results of studies with more sensitive techniques of assessing bone mass, for example neutron activation analysis and photon absorptiometry, before we make any firm conclusions about the importance of osteoporosis. Radiologic osteosclerosis of the spine is considered by some authors to be a feature of hyperparathyroidism [4, 27] but it also occurs in osteomalacia [281, and in our patients skeletal sclerosis correlated with both osteomalacia and osteitis fibrosa [171. There is no association between radiologic osteosclerosis and symptoms in this series (Table 4) .
Predictive value of biochemical changes. The expected correlation between serum alkaline phosphatase and osteitis fibrosa 119, 15, 29] was confirmed. A rise of alkaline phosphatase was also associated with radiologic features of hyperparathyroidism ( Table 5 ).
The correlation between alkaline phosphatase and osteid volume presumably reflects the fact that osteid volume is increased in hyperparathyroidism [11. We could not find the relationship between serum alkaline phosphatase and osteomalacia found by some workers [5, 11, 16, 30] (Fig. 1) . We think this unusual finding is due to the fact that we have two populations of patients with osteomalacia, one with what might be described as the common pattern, and the other with the "normal alkaline phosphatase" form of osteomalacia. As this latter syndrome does not respond to vitamin D derivatives, the serum alkaline phosphatase is of some use in predicting whether or not a dialysis patient with osteomalacia is likely to respond to such treatment. No other biochemical parameter measured had any diagnostic or predictive value.
